Evaluate Quality of Life in Type 2 Diabetes, Before and After Change to Insuline Glargine

Summary

Primary objective: To assess quality of Life (QoL) changes and treatment satisfaction in a real life situation in patients with Type 2 diabetes inadequately controlled on a combination of oral antidiabetic drugs (OAD) plus Neutral Protamine Hagedrone (NHP) insulin treatment that are switched to insulin glargine. Secondary objective: To determine: change in HbA1c, comparision of the incidence of symptomatic hypoglycemia and severe hypoglycemia before and after introduction of insulin glargine, change in weight, change in insulin dose.

Timeline

Start

2005-10

Primary completion

2008-03

Completion

2008-03

Drugs

Indications